Ceragenix Pharmaceuticals, Inc. (OTCBB: CGXP) is a biopharmaceutical company that iscovers, develops and commercializes anti-infective drugs based on its proprietary class of compounds, Ceragenins. Active against a broad range of gram positive and gram negative bacteria, these agents are being developed as anti-infective medical device coatings and as therapeutics for serious antibiotic-resistant organisms.